My Cart [ 0 ]
Home > Antibodies > A-Z Primary Antibodies > Human BDCA-2 Protein

Human BDCA-2 Protein

BDCA-2; BDCA2; CLECSF11; CLECSF7; DLEC; HECL; CLEC4C; CD303; BDCA2MGC125791; CD303; CLECSF11PRO34150; DLEC; DLECMGC125792; HECLMGC125793; MGC125789; PRO34150

Catalog No. Product Name Size List Price (US$) Quantity
PA000759-A0004 Amyloid B A4 (Phospho-Thr743/668) Polyclonal Antibody 100 ug 350.00
PA000759-A0004 Amyloid B A4 (Phospho-Thr743/668) Polyclonal Antibody 50 ug 250.00
Description

BP004514: Human BDCA-2 Protein with the N-hFc Tag

Source: The recombinant Human BDCA-2 Protein, (amino acids Phe46-Ile213) fused with a hFc tag at the N-terminus, was produced in HEK 293 cells.
Molecular Weight:The recombinant Human BDCA-2 protein with the hFc tag at the N-terminus has a predicted MW of 47.1 kDa. Due to glycosylation, the protein migrates to 60-66 kDa based on Tris-Bis PAGE result.
Activity: Immobilized recombinant Human BDCA-2 protein with the N-hFc tag at 0.5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Anti-BDCA-2 Antibody protein with the N-hFc tag with the EC50 of 11.8 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Human BDCA-2 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.

BP003403: Human BDCA-2 Protein with the N-mFc Tag

Source: The recombinant Human BDCA-2 Protein, (amino acids Glu19-Asn244) fused with a mFc tag at the N-terminus, was produced in HEK 293 cells.
Molecular Weight:The recombinant Human BDCA-2 protein with the mFc tag at the N-terminus has a predicted MW of 46.39 kDa. Due to glycosylation, the protein migrates to 55-65 kDa based on Tris-Bis PAGE result.
Activity: Immobilized recombinant Human BDCA-2 protein with the N-mFc tag at 0.5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-BDCA-2 Antibody protein with the N-hFc tag with the EC50 of 2.2 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Human BDCA-2 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.


Shipping: The recombinant Human BDCA-2 Protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 week, 2 to 8°C under sterile conditions after reconstitution.
6 months, -20 to -70°C under sterile conditions after reconstitution.

Related Links

See our Privacy Policy